FINGOLIMOD for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8,814 adverse event reports in the FDA FAERS database where FINGOLIMOD was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for FINGOLIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 8,901 | 12.6% | 34 | 921 |
| Multiple sclerosis relapse | 6,728 | 9.5% | 52 | 1,787 |
| Headache | 5,993 | 8.5% | 30 | 754 |
| Dizziness | 4,317 | 6.1% | 13 | 627 |
| White blood cell count decreased | 3,597 | 5.1% | 14 | 311 |
| Lymphocyte count decreased | 3,232 | 4.6% | 31 | 499 |
| Hypoaesthesia | 3,180 | 4.5% | 14 | 684 |
| Gait disturbance | 3,007 | 4.2% | 24 | 754 |
| Fall | 2,715 | 3.8% | 19 | 727 |
| Memory impairment | 2,623 | 3.7% | 8 | 310 |
| Malaise | 2,605 | 3.7% | 22 | 543 |
| Drug ineffective | 2,571 | 3.6% | 17 | 282 |
| Nausea | 2,446 | 3.5% | 18 | 431 |
| Central nervous system lesion | 2,416 | 3.4% | 22 | 437 |
| Pain | 2,370 | 3.3% | 17 | 484 |
Other Indications for FINGOLIMOD
Multiple sclerosis (43,123)
Product used for unknown indication (16,965)
Relapsing multiple sclerosis (851)
Multiple sclerosis relapse (355)
Secondary progressive multiple sclerosis (351)
Foetal exposure during pregnancy (319)
Primary progressive multiple sclerosis (66)
Multiple sclerosis relapse prophylaxis (53)
Progressive multiple sclerosis (20)
Clinically isolated syndrome (18)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)
TECFIDERA (806)